SELLAS Life Sciences Group, Inc. (SLS) Misses Q3 EPS by 35c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.33), $0.35 worse than the analyst estimate of $0.02.

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KB Home (KBH) PT Raised to $66 at UBS on Market Stabilisation and Execution
• Stay long AI-capex winners into the peak, Stifel says despite bubble fears